Jiannan Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiannan Han has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Jie Kang
Third Hospital of Shanxi Medical University Shanxi Bethune Hospital Shanxi Academy of Medical Sciences Tongji Shanxi Hospital Taiyuan 030032 China
2 shared publications - Junkang Zhao
Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, Shanxi Province, China
2 shared publications - Liyun Zhang
Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China
2 shared publications - Dan Ma
Third Hospital of Shanxi Medical University
1 shared publication - Hong Zhao
Rheumatology and Immunology Department, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, Shanxi, China
1 shared publication - Jingying Wu
Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital Taiyuan China
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1)
Investigating the Impact of Gut Microbiota and Immune Cells on Ankylosing Spondylitis From a Genetic Perspective: A Mendelian Randomization and Mediation Study
Background: Previous studies have separately reported causal relationships between gut microbiota and ankylosing spondylitis (AS), as well as between immune cells and AS. However, the potential causal relationships between gut microbiota/immune cells and AS have not been explored. In this study, we elucidated the role of gut microbiota in the progression of AS through the regulation of immune cells. Methods: Inverse‐variance weighted (IVW) was used as the primary analysis method, supplemented by MR‒Egger, simple mode, weighted median, and weighted mode methods to determine the causal relationships between gut microbiota and AS. Additionally, Bayesian weighted Mendelian randomization (BWMR) was used to identify the strongest causal associations, and mediation MR analysis was performed to explore the potential mediating role of immune cells in the relationship between gut microbiota and AS. Results: MR analysis identified 13 microbial taxa significantly associated with AS, of which eight were significantly associated with an increased risk of AS. Additionally, five microbial taxa were significantly associated with a reduced risk of AS. Furthermore, 19 immunophenotypes were significantly associated with AS, of which 11 were linked to an increased risk of AS. Additionally, eight immune cells were associated with a reduced risk of AS. Mediation MR analysis revealed that two immune cells mediated the causal relationships of two gut microbiota: CX3CR1 on monocyte mediated a 7.91% increase in AS risk through the CAG‐83 sp000435555 abundance in stool pathway, and CD45 on CD33 − HLA DR − mediated a 12.04% increase in AS risk through the Clostridium S felsineum abundance in stool pathway. Multiple sensitivity analyses confirmed the robustness of our results. Conclusion: This study is the first to reveal the causal relationships among gut microbiota, immune cells, and AS. These findings provide genetic evidence supporting a potential causal role of gut microbiota in AS, suggesting that immune cells may act as mediators.
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1)
Open AccessInvestigating the Impact of Gut Microbiota and Immune Cells on Ankylosing Spondylitis From a Genetic Perspective: A Mendelian Randomization and Mediation Study
Background: Previous studies have separately reported causal relationships between gut microbiota and ankylosing spondylitis (AS), as well as between immune cells and AS. However, the potential causal relationships between gut microbiota/immune cells and AS have not been explored. In this study, we elucidated the role of gut microbiota in the progression of AS through the regulation of immune cells. Methods: Inverse‐variance weighted (IVW) was used as the primary analysis method, supplemented by MR‒Egger, simple mode, weighted median, and weighted mode methods to determine the causal relationships between gut microbiota and AS. Additionally, Bayesian weighted Mendelian randomization (BWMR) was used to identify the strongest causal associations, and mediation MR analysis was performed to explore the potential mediating role of immune cells in the relationship between gut microbiota and AS. Results: MR analysis identified 13 microbial taxa significantly associated with AS, of which eight were significantly associated with an increased risk of AS. Additionally, five microbial taxa were significantly associated with a reduced risk of AS. Furthermore, 19 immunophenotypes were significantly associated with AS, of which 11 were linked to an increased risk of AS. Additionally, eight immune cells were associated with a reduced risk of AS. Mediation MR analysis revealed that two immune cells mediated the causal relationships of two gut microbiota: CX3CR1 on monocyte mediated a 7.91% increase in AS risk through the CAG‐83 sp000435555 abundance in stool pathway, and CD45 on CD33 − HLA DR − mediated a 12.04% increase in AS risk through the Clostridium S felsineum abundance in stool pathway. Multiple sensitivity analyses confirmed the robustness of our results. Conclusion: This study is the first to reveal the causal relationships among gut microbiota, immune cells, and AS. These findings provide genetic evidence supporting a potential causal role of gut microbiota in AS, suggesting that immune cells may act as mediators.
- Open Access
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1)
The Role of Inflammatory Cytokines in the Causal Pathway From Gut Microbiota to Sjögren’s Syndrome: Evidence From Mendelian Randomization
Purpose: Evidence is accumulating that links gut microbiota, a crucial component of the immune environment, to Sjogren’s syndrome (SS). The mechanisms underlying the influence of gut microbiota on the onset and development of SS are still not completely understood. To this end, we applied a Mendelian randomization (MR) framework to investigate whether inflammatory cytokines mediate the association of gut microbiota with SS. Methods: Our MR analysis leveraged publicly available GWAS data, including information on 211 gut microbiota taxa sourced from the MiBioGen consortium (18,340 participants), summary statistics for 91 inflammatory cytokines obtained from a study of 14,824 individuals, and genetic data for SS derived from the UK Biobank (407,746 participants). To investigate causal associations between gut microbiota and SS, we primarily employed the inverse variance weighted method, supported by additional techniques such as MR‐Egger, simple mode, weighted median, and weighted mode for validation. The potential mediating effect of inflammatory cytokines in the gut microbiota–SS relationship was investigated using both mediation MR and multivariable MR (MVMR) analyses. Results: MR analysis identified five microbiota taxa causally associated with SS. Particularly, class Gammaproteobacteria (OR = 3.468, 95% CI = 1.139–10.557, p = 0.029) and genus Peptococcus (OR = 1.722, 95% CI = 1.082–2.471, p = 0.022) were significantly associated with an increased risk of developing SS. Six inflammatory cytokines were identified as potentially causal, with Axin‐1 (OR = 2.556, 95% CI = 1.072–6.096, p = 0.034) and C‐X‐C motif chemokine 10 levels (CXCL10) (OR = 3.049, 95% CI = 1.428–6.513, p = 0.004) being the most critical contributors. Mediation MR analysis showed that Axin‐1 levels mediated 16.96% of the causal effect of class Gammaproteobacteria on SS, CXCL10 levels mediated 36.78% of the causal effect of genus Coprococcus3 on SS. Conclusion: The findings suggest that certain gut microbiota is sociated with an increased risk of SS, mediated by specific inflammatory cytokines.
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1)
Open AccessThe Role of Inflammatory Cytokines in the Causal Pathway From Gut Microbiota to Sjögren’s Syndrome: Evidence From Mendelian Randomization
Purpose: Evidence is accumulating that links gut microbiota, a crucial component of the immune environment, to Sjogren’s syndrome (SS). The mechanisms underlying the influence of gut microbiota on the onset and development of SS are still not completely understood. To this end, we applied a Mendelian randomization (MR) framework to investigate whether inflammatory cytokines mediate the association of gut microbiota with SS. Methods: Our MR analysis leveraged publicly available GWAS data, including information on 211 gut microbiota taxa sourced from the MiBioGen consortium (18,340 participants), summary statistics for 91 inflammatory cytokines obtained from a study of 14,824 individuals, and genetic data for SS derived from the UK Biobank (407,746 participants). To investigate causal associations between gut microbiota and SS, we primarily employed the inverse variance weighted method, supported by additional techniques such as MR‐Egger, simple mode, weighted median, and weighted mode for validation. The potential mediating effect of inflammatory cytokines in the gut microbiota–SS relationship was investigated using both mediation MR and multivariable MR (MVMR) analyses. Results: MR analysis identified five microbiota taxa causally associated with SS. Particularly, class Gammaproteobacteria (OR = 3.468, 95% CI = 1.139–10.557, p = 0.029) and genus Peptococcus (OR = 1.722, 95% CI = 1.082–2.471, p = 0.022) were significantly associated with an increased risk of developing SS. Six inflammatory cytokines were identified as potentially causal, with Axin‐1 (OR = 2.556, 95% CI = 1.072–6.096, p = 0.034) and C‐X‐C motif chemokine 10 levels (CXCL10) (OR = 3.049, 95% CI = 1.428–6.513, p = 0.004) being the most critical contributors. Mediation MR analysis showed that Axin‐1 levels mediated 16.96% of the causal effect of class Gammaproteobacteria on SS, CXCL10 levels mediated 36.78% of the causal effect of genus Coprococcus3 on SS. Conclusion: The findings suggest that certain gut microbiota is sociated with an increased risk of SS, mediated by specific inflammatory cytokines.